These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 25607760)

  • 1. Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
    Jin LX; Moses LE; Squires MH; Poultsides GA; Votanopoulos K; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Strasberg SM; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine E; Winslow ER; Saunders ND; Spolverato G; Maithel SK; Fields RC
    Ann Surg; 2015 Dec; 262(6):999-1005. PubMed ID: 25607760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
    Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
    Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
    Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
    Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
    Bilici A; Selcukbiricik F
    Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients.
    Zhao B; Huang X; Zhang J; Luo R; Lu H; Xu H; Huang B
    Rev Esp Enferm Dig; 2019 Feb; 111(2):111-120. PubMed ID: 30404528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.
    Gholami S; Janson L; Worhunsky DJ; Tran TB; Squires MH; Jin LX; Spolverato G; Votanopoulos KI; Schmidt C; Weber SM; Bloomston M; Cho CS; Levine EA; Fields RC; Pawlik TM; Maithel SK; Efron B; Norton JA; Poultsides GA
    J Am Coll Surg; 2015 Aug; 221(2):291-9. PubMed ID: 26206635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
    Squires MH; Kooby DA; Pawlik TM; Weber SM; Poultsides G; Schmidt C; Votanopoulos K; Fields RC; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Jin LX; Levine E; Cho CS; Bloomston M; Winslow E; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2014 Dec; 21(13):4202-10. PubMed ID: 25047464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients.
    Yamashita H; Deng J; Liang H; Seto Y
    Surgery; 2017 Jun; 161(6):1588-1596. PubMed ID: 28111043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma.
    Postlewait LM; Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Swords D; Jin LX; Cho CS; Winslow ER; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S832-9. PubMed ID: 26156656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma.
    Schoenleber SJ; Schnelldorfer T; Wood CM; Qin R; Sarr MG; Donohue JH
    J Gastrointest Surg; 2009 Jul; 13(7):1233-7. PubMed ID: 19367436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic score predicting lymph node metastasis in T1 gastric cancer.
    Tran TB; Worhunsky DJ; Squires MH; Jin LX; Spolverato G; Votanopoulos KI; Weber SM; Schmidt C; Levine EA; Fields RC; Pawlik TM; Maithel SK; Norton JA; Poultsides GA
    Surgery; 2018 Apr; 163(4):889-893. PubMed ID: 29398039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
    In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
    Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.
    Sakar B; Karagol H; Gumus M; Basaran M; Kaytan E; Argon A; Ustuner Z; Bavbek SE; Bugra D; Aykan FN
    Am J Clin Oncol; 2004 Apr; 27(2):205-9. PubMed ID: 15057162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patterns and timing of recurrence after curative resection for gastric cancer in China.
    Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
    World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.